Rosacea Marketing
Agency in India.

The category-awareness problem.
Why the marketing job is education, not lead-gen.

Global rosacea prevalence estimates run 5 to 10 per cent of the adult population in Fitzpatrick I-II skin populations, and lower — 2 to 4 per cent — in the Fitzpatrick III-V population that dominates India. The absolute prevalence in India is still meaningful (10 to 25 million adults), but recognition rates in primary care and even in general dermatology practice sit far below the actual case count. A rosacea patient in India typically cycles through two or three misdiagnoses (adult acne, contact dermatitis, seborrheic dermatitis, sometimes lupus) before reaching a correct diagnosis.

The marketing implication: for rosacea, the acquisition problem is not "the patient searched for a rosacea specialist and did not find our clinic." It is "the patient does not yet know they have rosacea." The dermatology practice that wants to build a rosacea-recognised sub-specialty needs to invest in category-education content that captures the searcher one step upstream — the researcher typing "why does my face keep flushing," "adult acne that will not respond to acne treatment," "red patches on my cheeks that come and go," or "rosacea versus acne how to tell."

The 8-to-14 month journey to correct diagnosis.
The nurture cadence.

The rosacea patient's decision cycle is longer than any dermatology vertical other than vitiligo. From first symptom to first WhatsApp intake to a dermatology practice averages 8 to 14 months. From first WhatsApp intake to first consult averages 3 to 8 weeks. The nurture infrastructure across this window matters more than any single-touch conversion optimisation.

The nurture cadence that captures rosacea LTV: an email or WhatsApp opt-in on the differential-diagnosis content pages ("get the rosacea-versus-acne guide"), a 4-part email or WhatsApp sequence delivered over four weeks covering trigger identification, treatment options, when to see a specialist, and what to expect from a consult, and a soft booking nudge in message five with an "I am ready to consult" opt-in. The nurture opt-in itself is high-intent — the researching patient who trades a WhatsApp contact for a rosacea-versus-acne guide is typically 4 to 8 weeks from booking.

The retention infrastructure after the consult: rosacea is a chronic-relapsing condition, and the patient booked for a first consult in month three typically needs a maintenance conversation in month six, a trigger-review in month nine, and a laser-consideration conversation in month twelve if the erythematotelangiectatic subtype is dominant. A retention SOP capturing this cadence produces Rs.35,000 to Rs.85,000 in LTV over a 24-month relationship.

PDL and IPL as marketing assets.
The procedural upside for a subset of patients.

Erythematotelangiectatic rosacea — the persistent-redness-and-telangiectasia subtype — responds meaningfully to vascular laser (pulsed dye laser, KTP laser) and intense pulsed light (IPL) approaches. For a dermatology practice with vascular laser or IPL capability, the ETR patient represents a procedural revenue stream that pharmacotherapy alone does not capture. The content architecture should include a dedicated page on laser and IPL for rosacea covering candidacy (ETR predominant, not papulopustular predominant), mechanism, typical protocol (four to eight sessions), cost-band range, and outcome as improvement-with-maintenance rather than permanent removal.

The compliance frame for laser rosacea content: the ETR patient responds to vascular laser but the response is partial and maintenance-requiring; content should never promise permanent redness clearance. The Meta ad review picture for vascular laser and IPL rosacea creative: it does trigger Personal Attributes review inconsistently. The workaround is publishing laser-rosacea content as organic Reels and Instagram carousels rather than as boosted ads, or running paid creative on the differential-diagnosis and general-treatment content and letting the vascular-laser conversation happen in the WhatsApp intake and consult stage rather than in the ad.

The category where AEO wins disproportionately.
Dermatologist authority for rosacea queries.

Rosacea queries — "what is rosacea," "rosacea versus acne," "rosacea triggers," "ivermectin for rosacea" — are heavily AI-Overview-cited in Indian Google search and heavily surfaced through ChatGPT for the researching patient. The category is under-served by competing content, which means a compliance-serious dermatology practice publishing depth-content on rosacea can earn AI Overview citations and ChatGPT source-inclusion within four to seven months of publishing.

The AEO work: structure every rosacea page for extraction (definition sentence, bulleted elaboration, longer discussion), mirror headings to the questions patients type ("Why does my face keep flushing?" outperforms "Rosacea overview" as an H2), publish FAQPage schema on every hub and spoke, use named-author bylines with credentials, photograph and a linked biography page. For rosacea specifically, the referral bridge to dermatologist consultation should be the CTA on the AEO-optimised content — the researcher who lands via AI Overview citation is the highest-intent researcher in the vertical.

About rosacea marketing
in India.